心嚢穿刺処置の世界市場2019-2027

◆英語タイトル:Pericardiocentesis Procedures - Global Market Outlook (2019-2027)
◆商品コード:SMRC20JL353
◆発行会社(リサーチ会社):Stratistics MRC
◆発行日:2020年6月30日
◆ページ数:198
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥435,750見積依頼/購入/質問フォーム
Five UserUSD5,250 ⇒換算¥551,250見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥787,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Stratistics MRC社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、心嚢穿刺処置の世界市場を広く調査・分析し、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、疾患別(心臓病、感染症、炎症性/リウマチ、悪性腫瘍)分析、エンドユーザー別分析、地域別分析、主要な市場開拓、企業情報など、今後の市場展望をまとめております。
・エグゼクティブサマリー
・序論
・市場動向分析
・ファイブフォース分析
・心嚢穿刺処置の世界市場規模:疾患別(心臓病、感染症、炎症性/リウマチ、悪性腫瘍)
・心嚢穿刺処置の世界市場規模:エンドユーザー別
・心嚢穿刺処置の世界市場規模:地域別
・主要な市場開拓
・企業情報
【レポートの概要】

According to Stratistics MRC, the Global Pericardiocentesis Procedures Market is accounted for $144.30 million in 2019 and is expected to reach $230.00 million by 2027 growing at a CAGR of 6.0% during the forecast period. Increase in the geriatric population and high adoption of minimally invasive surgeries for treatment of different medical conditions are the major factors propelling the market growth. However, complications and risk associated with the surgery are hampering the market growth.

Pericardiocentesis is a minimally invasive surgical procedure performed to remove the excess levels of fluid accumulated in the pericardium sac around the heart. The procedure involves the usage of a small needle, which is inserted into the pericardium sac, and a catheter to remove the fluid. Several factors lead to the development of pericardial effusion (excess fluid accumulated in the pericardium). The underlying causes of pericardial effusion are viral, bacterial, and parasitic infections, tuberculosis, breast & lung cancer, end-stage renal diseases, and postoperative cardiac surgery complication. Of the different causes of pericardial effusion, malignancies and cardiovascular diseases are the most common causes, accounting for more than 50% of total pericardial effusion reported cases.

Based on the end-user, the hospital’s segment is going to have a lucrative growth during the forecast period owing to the improved treatments of cardiac tamponade across the globe. Well-established surgical infrastructure in hospitals, rise in hospitalization for the underlying causes of cardiac tamponade, and a large number of chemotherapy and radiation therapy treatments in hospitals contributed to the segment’s large share of the global market.

By geography, North America is going to have a lucrative growth during the forecast period due to the high prevalence and increase in the incidence of cancer and cardiovascular diseases in the U.S. and Canada, and well-established healthcare facilities. High per capita healthcare expenditure, favourable medical reimbursement policies, and early adoption of minimally invasive surgeries can be attributed to the region’s large share of the global pericardiocentesis procedures market.

Some of the key players profiled in the Pericardiocentesis Procedures Market include Cleveland Clinic, NewYork-Presbyterian Hospital, The Johns Hopkins Hospital, Saint George Hospital, Buddhist Tzu Chi Medical Foundation, J.W. Goethe University Hospital, The University of Tokyo Hospital, Mediclinic International, Apollo Hospitals Enterprise Ltd, and Florida Hospital Orlando.

Indications Covered:
• Cardiac
• Infections
• Inflammatory/Rheumatology
• Malignancies

End Users Covered:
• Cardiac Centers
• Hospitals

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019 2020, 2024, and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client’s interest (Note: Depends on feasibility check)
• Competitive Benchmarking
o Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 End User Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Pericardiocentesis Procedures Market, By Indication
5.1 Introduction
5.2 Cardiac
5.3 Infections
5.3.1 Bacterial Infection
5.3.2 Tuberculosis Infection
5.4 Inflammatory/Rheumatology
5.4.1 Rheumatoid Arthritis
5.4.2 Systemic Lupus Erythromatosus
5.5 Malignancies
5.5.1 Breast Cancer
5.5.2 Lung Cancer
5.5.3 Lymphoma

6 Global Pericardiocentesis Procedures Market, By End User
6.1 Introduction
6.2 Cardiac Centers
6.3 Hospitals

7 Global Pericardiocentesis Procedures Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 UK
7.3.3 Italy
7.3.4 France
7.3.5 Spain
7.3.6 Rest of Europe
7.4 Asia Pacific
7.4.1 Japan
7.4.2 China
7.4.3 India
7.4.4 Australia
7.4.5 New Zealand
7.4.6 South Korea
7.4.7 Rest of Asia Pacific
7.5 South America
7.5.1 Argentina
7.5.2 Brazil
7.5.3 Chile
7.5.4 Rest of South America
7.6 Middle East & Africa
7.6.1 Saudi Arabia
7.6.2 UAE
7.6.3 Qatar
7.6.4 South Africa
7.6.5 Rest of Middle East & Africa

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 Cleveland Clinic
9.2 NewYork-Presbyterian Hospital
9.3 The Johns Hopkins Hospital
9.4 Saint George Hospital
9.5 Buddhist Tzu Chi Medical Foundation
9.6 J.W. Goethe University Hospital
9.7 The University of Tokyo Hospital
9.8 Mediclinic International
9.9 Apollo Hospitals Enterprise Ltd
9.10 Florida Hospital Orlando

List of Tables
Table 1 Global Pericardiocentesis Procedures Market Outlook, By Region (2018-2027) ($MN)
Table 2 Global Pericardiocentesis Procedures Market Outlook, By Indication (2018-2027) ($MN)
Table 3 Global Pericardiocentesis Procedures Market Outlook, By Cardiac (2018-2027) ($MN)
Table 4 Global Pericardiocentesis Procedures Market Outlook, By Infections (2018-2027) ($MN)
Table 5 Global Pericardiocentesis Procedures Market Outlook, By Bacterial Infection (2018-2027) ($MN)
Table 6 Global Pericardiocentesis Procedures Market Outlook, By Tuberculosis Infection (2018-2027) ($MN)
Table 7 Global Pericardiocentesis Procedures Market Outlook, By Inflammatory/Rheumatology (2018-2027) ($MN)
Table 8 Global Pericardiocentesis Procedures Market Outlook, By Rheumatoid Arthritis (2018-2027) ($MN)
Table 9 Global Pericardiocentesis Procedures Market Outlook, By Systemic Lupus Erythromatosus (2018-2027) ($MN)
Table 10 Global Pericardiocentesis Procedures Market Outlook, By Malignancies (2018-2027) ($MN)
Table 11 Global Pericardiocentesis Procedures Market Outlook, By Breast Cancer (2018-2027) ($MN)
Table 12 Global Pericardiocentesis Procedures Market Outlook, By Lung Cancer (2018-2027) ($MN)
Table 13 Global Pericardiocentesis Procedures Market Outlook, By Lymphoma (2018-2027) ($MN)
Table 14 Global Pericardiocentesis Procedures Market Outlook, By End User (2018-2027) ($MN)
Table 15 Global Pericardiocentesis Procedures Market Outlook, By Cardiac Centers (2018-2027) ($MN)
Table 16 Global Pericardiocentesis Procedures Market Outlook, By Hospitals (2018-2027) ($MN)
Table 17 North America Pericardiocentesis Procedures Market Outlook, By Country (2018-2027) ($MN)
Table 18 North America Pericardiocentesis Procedures Market Outlook, By Indication (2018-2027) ($MN)
Table 19 North America Pericardiocentesis Procedures Market Outlook, By Cardiac (2018-2027) ($MN)
Table 20 North America Pericardiocentesis Procedures Market Outlook, By Infections (2018-2027) ($MN)
Table 21 North America Pericardiocentesis Procedures Market Outlook, By Bacterial Infection (2018-2027) ($MN)
Table 22 North America Pericardiocentesis Procedures Market Outlook, By Tuberculosis Infection (2018-2027) ($MN)
Table 23 North America Pericardiocentesis Procedures Market Outlook, By Inflammatory/Rheumatology (2018-2027) ($MN)
Table 24 North America Pericardiocentesis Procedures Market Outlook, By Rheumatoid Arthritis (2018-2027) ($MN)
Table 25 North America Pericardiocentesis Procedures Market Outlook, By Systemic Lupus Erythromatosus (2018-2027) ($MN)
Table 26 North America Pericardiocentesis Procedures Market Outlook, By Malignancies (2018-2027) ($MN)
Table 27 North America Pericardiocentesis Procedures Market Outlook, By Breast Cancer (2018-2027) ($MN)
Table 28 North America Pericardiocentesis Procedures Market Outlook, By Lung Cancer (2018-2027) ($MN)
Table 29 North America Pericardiocentesis Procedures Market Outlook, By Lymphoma (2018-2027) ($MN)
Table 30 North America Pericardiocentesis Procedures Market Outlook, By End User (2018-2027) ($MN)
Table 31 North America Pericardiocentesis Procedures Market Outlook, By Cardiac Centers (2018-2027) ($MN)
Table 32 North America Pericardiocentesis Procedures Market Outlook, By Hospitals (2018-2027) ($MN)
Table 33 Europe Pericardiocentesis Procedures Market Outlook, By Country (2018-2027) ($MN)
Table 34 Europe Pericardiocentesis Procedures Market Outlook, By Indication (2018-2027) ($MN)
Table 35 Europe Pericardiocentesis Procedures Market Outlook, By Cardiac (2018-2027) ($MN)
Table 36 Europe Pericardiocentesis Procedures Market Outlook, By Infections (2018-2027) ($MN)
Table 37 Europe Pericardiocentesis Procedures Market Outlook, By Bacterial Infection (2018-2027) ($MN)
Table 38 Europe Pericardiocentesis Procedures Market Outlook, By Tuberculosis Infection (2018-2027) ($MN)
Table 39 Europe Pericardiocentesis Procedures Market Outlook, By Inflammatory/Rheumatology (2018-2027) ($MN)
Table 40 Europe Pericardiocentesis Procedures Market Outlook, By Rheumatoid Arthritis (2018-2027) ($MN)
Table 41 Europe Pericardiocentesis Procedures Market Outlook, By Systemic Lupus Erythromatosus (2018-2027) ($MN)
Table 42 Europe Pericardiocentesis Procedures Market Outlook, By Malignancies (2018-2027) ($MN)
Table 43 Europe Pericardiocentesis Procedures Market Outlook, By Breast Cancer (2018-2027) ($MN)
Table 44 Europe Pericardiocentesis Procedures Market Outlook, By Lung Cancer (2018-2027) ($MN)
Table 45 Europe Pericardiocentesis Procedures Market Outlook, By Lymphoma (2018-2027) ($MN)
Table 46 Europe Pericardiocentesis Procedures Market Outlook, By End User (2018-2027) ($MN)
Table 47 Europe Pericardiocentesis Procedures Market Outlook, By Cardiac Centers (2018-2027) ($MN)
Table 48 Europe Pericardiocentesis Procedures Market Outlook, By Hospitals (2018-2027) ($MN)
Table 49 Asia Pacific Pericardiocentesis Procedures Market Outlook, By Country (2018-2027) ($MN)
Table 50 Asia Pacific Pericardiocentesis Procedures Market Outlook, By Indication (2018-2027) ($MN)
Table 51 Asia Pacific Pericardiocentesis Procedures Market Outlook, By Cardiac (2018-2027) ($MN)
Table 52 Asia Pacific Pericardiocentesis Procedures Market Outlook, By Infections (2018-2027) ($MN)
Table 53 Asia Pacific Pericardiocentesis Procedures Market Outlook, By Bacterial Infection (2018-2027) ($MN)
Table 54 Asia Pacific Pericardiocentesis Procedures Market Outlook, By Tuberculosis Infection (2018-2027) ($MN)
Table 55 Asia Pacific Pericardiocentesis Procedures Market Outlook, By Inflammatory/Rheumatology (2018-2027) ($MN)
Table 56 Asia Pacific Pericardiocentesis Procedures Market Outlook, By Rheumatoid Arthritis (2018-2027) ($MN)
Table 57 Asia Pacific Pericardiocentesis Procedures Market Outlook, By Systemic Lupus Erythromatosus (2018-2027) ($MN)
Table 58 Asia Pacific Pericardiocentesis Procedures Market Outlook, By Malignancies (2018-2027) ($MN)
Table 59 Asia Pacific Pericardiocentesis Procedures Market Outlook, By Breast Cancer (2018-2027) ($MN)
Table 60 Asia Pacific Pericardiocentesis Procedures Market Outlook, By Lung Cancer (2018-2027) ($MN)
Table 61 Asia Pacific Pericardiocentesis Procedures Market Outlook, By Lymphoma (2018-2027) ($MN)
Table 62 Asia Pacific Pericardiocentesis Procedures Market Outlook, By End User (2018-2027) ($MN)
Table 63 Asia Pacific Pericardiocentesis Procedures Market Outlook, By Cardiac Centers (2018-2027) ($MN)
Table 64 Asia Pacific Pericardiocentesis Procedures Market Outlook, By Hospitals (2018-2027) ($MN)
Table 65 South America Pericardiocentesis Procedures Market Outlook, By Country (2018-2027) ($MN)
Table 66 South America Pericardiocentesis Procedures Market Outlook, By Indication (2018-2027) ($MN)
Table 67 South America Pericardiocentesis Procedures Market Outlook, By Cardiac (2018-2027) ($MN)
Table 68 South America Pericardiocentesis Procedures Market Outlook, By Infections (2018-2027) ($MN)
Table 69 South America Pericardiocentesis Procedures Market Outlook, By Bacterial Infection (2018-2027) ($MN)
Table 70 South America Pericardiocentesis Procedures Market Outlook, By Tuberculosis Infection (2018-2027) ($MN)
Table 71 South America Pericardiocentesis Procedures Market Outlook, By Inflammatory/Rheumatology (2018-2027) ($MN)
Table 72 South America Pericardiocentesis Procedures Market Outlook, By Rheumatoid Arthritis (2018-2027) ($MN)
Table 73 South America Pericardiocentesis Procedures Market Outlook, By Systemic Lupus Erythromatosus (2018-2027) ($MN)
Table 74 South America Pericardiocentesis Procedures Market Outlook, By Malignancies (2018-2027) ($MN)
Table 75 South America Pericardiocentesis Procedures Market Outlook, By Breast Cancer (2018-2027) ($MN)
Table 76 South America Pericardiocentesis Procedures Market Outlook, By Lung Cancer (2018-2027) ($MN)
Table 77 South America Pericardiocentesis Procedures Market Outlook, By Lymphoma (2018-2027) ($MN)
Table 78 South America Pericardiocentesis Procedures Market Outlook, By End User (2018-2027) ($MN)
Table 79 South America Pericardiocentesis Procedures Market Outlook, By Cardiac Centers (2018-2027) ($MN)
Table 80 South America Pericardiocentesis Procedures Market Outlook, By Hospitals (2018-2027) ($MN)
Table 81 Middle East & Africa Pericardiocentesis Procedures Market Outlook, By Country (2018-2027) ($MN)
Table 82 Middle East & Africa Pericardiocentesis Procedures Market Outlook, By Indication (2018-2027) ($MN)
Table 83 Middle East & Africa Pericardiocentesis Procedures Market Outlook, By Cardiac (2018-2027) ($MN)
Table 84 Middle East & Africa Pericardiocentesis Procedures Market Outlook, By Infections (2018-2027) ($MN)
Table 85 Middle East & Africa Pericardiocentesis Procedures Market Outlook, By Bacterial Infection (2018-2027) ($MN)
Table 86 Middle East & Africa Pericardiocentesis Procedures Market Outlook, By Tuberculosis Infection (2018-2027) ($MN)
Table 87 Middle East & Africa Pericardiocentesis Procedures Market Outlook, By Inflammatory/Rheumatology (2018-2027) ($MN)
Table 88 Middle East & Africa Pericardiocentesis Procedures Market Outlook, By Rheumatoid Arthritis (2018-2027) ($MN)
Table 89 Middle East & Africa Pericardiocentesis Procedures Market Outlook, By Systemic Lupus Erythromatosus (2018-2027) ($MN)
Table 90 Middle East & Africa Pericardiocentesis Procedures Market Outlook, By Malignancies (2018-2027) ($MN)
Table 91 Middle East & Africa Pericardiocentesis Procedures Market Outlook, By Breast Cancer (2018-2027) ($MN)
Table 92 Middle East & Africa Pericardiocentesis Procedures Market Outlook, By Lung Cancer (2018-2027) ($MN)
Table 93 Middle East & Africa Pericardiocentesis Procedures Market Outlook, By Lymphoma (2018-2027) ($MN)
Table 94 Middle East & Africa Pericardiocentesis Procedures Market Outlook, By End User (2018-2027) ($MN)
Table 95 Middle East & Africa Pericardiocentesis Procedures Market Outlook, By Cardiac Centers (2018-2027) ($MN)
Table 96 Middle East & Africa Pericardiocentesis Procedures Market Outlook, By Hospitals (2018-2027) ($MN)



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[心嚢穿刺処置の世界市場2019-2027]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆